2025. G-protein Coupled Receptors (GPCRs): A Potential Target of Apigenin as a Novel hACE2 Receptor Specific Therapeutic for Impeding Lung Cancer Considering a Group of Missense and Nonsense Mutations in COVID-19 Patients. European Journal of Pharmaceutical Research. 5, 1 (May 2025), 6–15. DOI:https://doi.org/10.24018/ejpharma.2025.5.1.85.